Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles
Ardelyx sues CMS over revamped kidney disease drug payment bundle – Pharmaceutical Technology
Experts are preparing a dialysis machine for use in critically ill patients in hospital intensive care units. Ardelyx and other kidney organisations are seeking litigation